139 related articles for article (PubMed ID: 9866001)
21. Hormonal treatment for bleeding irregularities in Norplant implant users.
Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
[TBL] [Abstract][Full Text] [Related]
22. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
23. New concepts in contraception: Norplant subdermal implant.
Lynn MM; Holdcroft C
Nurse Pract; 1992 Mar; 17(3):85-9. PubMed ID: 1565306
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
Au CL; Affandi B; Rogers PA
Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of gestagens: some problems.
Fotherby K
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297
[TBL] [Abstract][Full Text] [Related]
26. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
[TBL] [Abstract][Full Text] [Related]
27. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Anwar M; Soejono SK; Maruo T; Abdullah N
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
[TBL] [Abstract][Full Text] [Related]
28. Influence of high doses of vitamin C on the bioavailability and the serum protein binding of levonorgestrel in women using a combination oral contraceptive.
Kuhnz W; Louton T; Hümpel M; Back DJ; Zamah NM
Contraception; 1995 Feb; 51(2):111-6. PubMed ID: 7750288
[TBL] [Abstract][Full Text] [Related]
29. Effect of Norplant implants on the pituitary-adrenal axis function and reserve capacity.
Toppozada MK; Ramadan M; el-Sawi M; Mehanna MT; Khamis Y; Marzouk S
Contraception; 1997 Jan; 55(1):7-10. PubMed ID: 9013054
[TBL] [Abstract][Full Text] [Related]
30. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants.
Odlind V; Olsson SE
Contraception; 1986 Mar; 33(3):257-61. PubMed ID: 3087695
[TBL] [Abstract][Full Text] [Related]
31. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
Goodger AM; Rogers PA; Affandi B
Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
[TBL] [Abstract][Full Text] [Related]
32. Assessing the acceptability of Norplant contraceptive in four patient populations.
Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
[TBL] [Abstract][Full Text] [Related]
33. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
Song S; Chen JK; He ML; Fotherby K
Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
Toddyvalla V; Johannisson E; Landgren BM; Cekan SZ; Diczfalusy E
Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759
[TBL] [Abstract][Full Text] [Related]
35. Education and counseling for Norplant users.
Hinkle LT
J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
[TBL] [Abstract][Full Text] [Related]
36. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
37. Use of Norplant implants in a New York City clinic population.
Gerber S; Westhoff C; Lopez M; Gordon L
Contraception; 1994 Jun; 49(6):557-64. PubMed ID: 8070260
[TBL] [Abstract][Full Text] [Related]
38. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
[TBL] [Abstract][Full Text] [Related]
39. Free levonorgestrel index and its relationship with luteal activity during long-term use of Norplant implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Adv Contracept; 1992 Dec; 8(4):319-26. PubMed ID: 1365818
[TBL] [Abstract][Full Text] [Related]
40. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
